Block & Leviton today filed a motion seeking preliminary approval of a $40 million settlement in the long-running securities case against Immunomedics (which has since been acquired) and its executives. Additional details about the settlement are available on the case website.
Block & Leviton is co-lead counsel with Robbins, Geller, Rudman & Dowd LLP in this litigation.